days healthcare u.k. limited
days healthcare u.k. limited Company Information
Company Number
01120623
Next Accounts
Dec 2025
Shareholders
dcc mobility & rehab ltd
Group Structure
View All
Industry
Other manufacturing n.e.c.
Registered Address
9-12 hardwick road, astmoor industrial estate, runcorn, cheshire, WA7 1PH
days healthcare u.k. limited Estimated Valuation
Pomanda estimates the enterprise value of DAYS HEALTHCARE U.K. LIMITED at £0 based on a Turnover of £0 and 0.67x industry multiple (adjusted for size and gross margin).
days healthcare u.k. limited Estimated Valuation
Pomanda estimates the enterprise value of DAYS HEALTHCARE U.K. LIMITED at £4.5k based on an EBITDA of £1k and a 4.5x industry multiple (adjusted for size and gross margin).
days healthcare u.k. limited Estimated Valuation
Pomanda estimates the enterprise value of DAYS HEALTHCARE U.K. LIMITED at £18.6m based on Net Assets of £8.7m and 2.14x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Days Healthcare U.k. Limited Overview
Days Healthcare U.k. Limited is a live company located in runcorn, WA7 1PH with a Companies House number of 01120623. It operates in the other manufacturing n.e.c. sector, SIC Code 32990. Founded in June 1973, it's largest shareholder is dcc mobility & rehab ltd with a 100% stake. Days Healthcare U.k. Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Days Healthcare U.k. Limited Health Check
Pomanda's financial health check has awarded Days Healthcare U.K. Limited a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 2 areas for improvement. Company Health Check FAQs
0 Strong
1 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Days Healthcare U.k. Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Days Healthcare U.k. Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Days Healthcare U.k. Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Days Healthcare U.k. Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (70)
- Days Healthcare U.k. Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Days Healthcare U.k. Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Days Healthcare U.k. Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Days Healthcare U.k. Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Days Healthcare U.k. Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Days Healthcare U.k. Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 3 weeks, this is less cash available to meet short term requirements (14 weeks)
- - Days Healthcare U.k. Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 42.4%, this is a similar level of debt than the average (46.5%)
- - Days Healthcare U.k. Limited
- - Industry AVG
DAYS HEALTHCARE U.K. LIMITED financials
Days Healthcare U.K. Limited's latest turnover from March 2024 is 0 and the company has net assets of £8.7 million. According to their latest financial statements, we estimate that Days Healthcare U.K. Limited has 1 employee and maintains cash reserves of £443 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 21,860,000 | ||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 17,083,000 | ||||||||||||||
| Gross Profit | 4,777,000 | ||||||||||||||
| Admin Expenses | 4,670,000 | ||||||||||||||
| Operating Profit | 1,000 | -9,000 | 107,000 | ||||||||||||
| Interest Payable | 384,000 | ||||||||||||||
| Interest Receivable | 534,000 | 240,000 | 20,000 | 10,000 | 74,000 | ||||||||||
| Pre-Tax Profit | 535,000 | 231,000 | 74,000 | 16,000 | 27,000 | -277,000 | |||||||||
| Tax | -125,000 | -32,000 | -2,000 | 1,000 | 2,734,000 | -146,000 | |||||||||
| Profit After Tax | 410,000 | 199,000 | 72,000 | 17,000 | 2,761,000 | -423,000 | |||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | 410,000 | 199,000 | 72,000 | 17,000 | 2,761,000 | -423,000 | |||||||||
| Employee Costs | 2,964,000 | ||||||||||||||
| Number Of Employees | 3 | 3 | 3 | 113 | |||||||||||
| EBITDA* | 1,000 | -9,000 | 306,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 964,000 | ||||||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | 2,720,000 | ||||||||||||||
| Debtors (Due After 1 year) | 2,100,000 | ||||||||||||||
| Total Fixed Assets | 5,784,000 | ||||||||||||||
| Stock & work in progress | 4,575,000 | ||||||||||||||
| Trade Debtors | 2,294,000 | ||||||||||||||
| Group Debtors | 11,657,000 | 11,377,000 | 11,158,000 | 11,149,000 | 11,213,000 | 811,000 | |||||||||
| Misc Debtors | 2,983,000 | 3,112,000 | 3,143,000 | 3,145,000 | 3,144,000 | 1,156,000 | |||||||||
| Cash | 443,000 | 190,000 | 171,000 | 108,000 | 35,000 | 1,265,000 | |||||||||
| misc current assets | |||||||||||||||
| total current assets | 15,083,000 | 14,679,000 | 14,472,000 | 14,402,000 | 14,392,000 | 10,101,000 | |||||||||
| total assets | 15,083,000 | 14,679,000 | 14,472,000 | 14,402,000 | 14,392,000 | 15,885,000 | |||||||||
| Bank overdraft | 24,000 | ||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 2,716,000 | ||||||||||||||
| Group/Directors Accounts | 6,394,000 | 6,400,000 | 6,392,000 | 6,394,000 | 6,401,000 | 2,764,000 | |||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,221,000 | |||||||||
| total current liabilities | 6,395,000 | 6,401,000 | 6,393,000 | 6,395,000 | 6,402,000 | 6,725,000 | |||||||||
| loans | 5,886,000 | ||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | 680,000 | ||||||||||||||
| total long term liabilities | 6,566,000 | ||||||||||||||
| total liabilities | 6,395,000 | 6,401,000 | 6,393,000 | 6,395,000 | 6,402,000 | 13,291,000 | |||||||||
| net assets | 8,688,000 | 8,278,000 | 8,079,000 | 8,007,000 | 7,990,000 | 2,594,000 | |||||||||
| total shareholders funds | 8,688,000 | 8,278,000 | 8,079,000 | 8,007,000 | 7,990,000 | 2,594,000 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 1,000 | -9,000 | 107,000 | ||||||||||||
| Depreciation | 199,000 | ||||||||||||||
| Amortisation | |||||||||||||||
| Tax | -125,000 | -32,000 | -2,000 | 1,000 | 2,734,000 | -146,000 | |||||||||
| Stock | -4,575,000 | 4,575,000 | |||||||||||||
| Debtors | 151,000 | 188,000 | 7,000 | -63,000 | 14,357,000 | -6,361,000 | 6,361,000 | ||||||||
| Creditors | -2,716,000 | 2,716,000 | |||||||||||||
| Accruals and Deferred Income | 1,000 | -1,221,000 | 1,221,000 | ||||||||||||
| Deferred Taxes & Provisions | -680,000 | 680,000 | |||||||||||||
| Cash flow from operations | -275,000 | -229,000 | -6,159,000 | ||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | -2,720,000 | 2,720,000 | |||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -6,000 | 8,000 | -2,000 | -7,000 | 6,401,000 | -2,764,000 | 2,764,000 | ||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | -5,886,000 | 5,886,000 | |||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 534,000 | 240,000 | 20,000 | 10,000 | 74,000 | -384,000 | |||||||||
| cash flow from financing | 528,000 | 248,000 | 18,000 | 3,000 | 11,704,000 | 11,283,000 | |||||||||
| cash and cash equivalents | |||||||||||||||
| cash | 253,000 | 19,000 | 63,000 | 73,000 | 35,000 | -1,265,000 | 1,265,000 | ||||||||
| overdraft | -24,000 | 24,000 | |||||||||||||
| change in cash | 253,000 | 19,000 | 63,000 | 73,000 | 35,000 | -1,241,000 | 1,241,000 |
days healthcare u.k. limited Credit Report and Business Information
Days Healthcare U.k. Limited Competitor Analysis
Perform a competitor analysis for days healthcare u.k. limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mature companies, companies in WA7 area or any other competitors across 12 key performance metrics.
days healthcare u.k. limited Ownership
DAYS HEALTHCARE U.K. LIMITED group structure
Days Healthcare U.K. Limited has no subsidiary companies.
Ultimate parent company
DCC PUBLIC LIMITED COMPANY
IE054858
2 parents
DAYS HEALTHCARE U.K. LIMITED
01120623
days healthcare u.k. limited directors
Days Healthcare U.K. Limited currently has 3 directors. The longest serving directors include Mr Conor Costigan (Jan 2004) and Mr Anthony Levy (Jun 2010).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Conor Costigan | United Kingdom | 54 years | Jan 2004 | - | Director |
| Mr Anthony Levy | United Kingdom | 67 years | Jun 2010 | - | Director |
| Mr Michael Alden | 75 years | May 2013 | - | Director |
P&L
March 2024turnover
0
0%
operating profit
1k
-111%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
8.7m
+0.05%
total assets
15.1m
+0.03%
cash
443k
+1.33%
net assets
Total assets minus all liabilities
Similar Companies
days healthcare u.k. limited company details
company number
01120623
Type
Private limited with Share Capital
industry
32990 - Other manufacturing n.e.c.
incorporation date
June 1973
age
52
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
days medical aids limited (November 2004)
accountant
-
auditor
KPMG
address
9-12 hardwick road, astmoor industrial estate, runcorn, cheshire, WA7 1PH
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
LOVELLS
days healthcare u.k. limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to days healthcare u.k. limited. Currently there are 0 open charges and 4 have been satisfied in the past.
days healthcare u.k. limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DAYS HEALTHCARE U.K. LIMITED. This can take several minutes, an email will notify you when this has completed.
days healthcare u.k. limited Companies House Filings - See Documents
| date | description | view/download |
|---|
